Please Wait
Applying Filters...
menu
    • menu
    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Olmesartan Medoxomil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 681Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of August 20, 2025
    Enforcement Report - Week of August 20, 2025

    20 Aug 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-20-2025-4773.pdf

    FDA
    20 Aug 2025
    Share Share
    Hetero's Generics HCTZ Olmesartan Receives Approval in US
    Hetero's Generics HCTZ Olmesartan Receives Approval in US

    25 Jul 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209199

    FDA
    25 Jul 2025
    Share Share
    Macleods’s Generics Olmesartan Combo Receives Approval in US
    Macleods’s Generics Olmesartan Combo Receives Approval in US

    18 Jul 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207088

    FDA
    18 Jul 2025
    Share Share
    Amneal's Generic Olmesartan Medoxomil Receives Approval in the U.S.
    Amneal's Generic Olmesartan Medoxomil Receives Approval in the U.S.

    11 Jul 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207480

    FDA
    11 Jul 2023
    Share Share
    Macleods' Generic Olmesartan Medoxomil and Hydrochlorothiazide Receives Receives Approval in the U.S.
    Macleods' Generic Olmesartan Medoxomil and Hydrochlorothiazide Receives Receives Approval in the U.S.

    01 Jun 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204801

    FDA
    01 Jun 2023
    Share Share
    MSN's Generic Olmesartan Medoxomil Receives Approval in the U.S.
    MSN's Generic Olmesartan Medoxomil Receives Approval in the U.S.

    18 Jan 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217399

    FDA
    18 Jan 2023
    Share Share